Burleson & Co’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $2.05M | Buy |
18,438
+3,746
| +25% | +$416K | 0.51% | 58 |
|
|
2022
Q3 | $1.27M | Buy |
14,692
+1,981
| +16% | +$171K | 0.27% | 65 |
|
|
2022
Q2 | $1.16M | Buy |
12,711
+10
| +0.1% | +$912 | 0.25% | 66 |
|
|
2022
Q1 | $1.04M | Sell |
12,701
-18
| -0.1% | -$1.48K | 0.17% | 81 |
|
|
2021
Q4 | $975K | Sell |
12,719
-162
| -1% | -$12.4K | 0.14% | 79 |
|
|
2021
Q3 | $968K | Buy |
12,881
+3
| +0% | +$225 | 0.14% | 71 |
|
|
2021
Q2 | $1M | Sell |
12,878
-1,165
| -8% | -$90.6K | 0.15% | 74 |
|
|
2021
Q1 | $1.03M | Sell |
14,043
-239
| -2% | -$17.6K | 0.17% | 73 |
|
|
2020
Q4 | $1.12M | Buy |
14,282
+340
| +2% | +$26.5K | 0.19% | 76 |
|
|
2020
Q3 | $1.07M | Buy |
13,942
+215
| +2% | +$16.5K | 0.2% | 77 |
|
|
2020
Q2 | $1.06M | Sell |
13,727
-267
| -2% | -$20.6K | 0.23% | 75 |
|
|
2020
Q1 | $1.02M | Buy |
13,994
+245
| +2% | +$17.9K | 0.27% | 73 |
|
|
2019
Q4 | $1.18M | Buy |
13,749
+1
| +0% | +$86 | 0.33% | 71 |
|
|
2019
Q3 | $1.09M | Buy |
13,748
+538
| +4% | +$42.5K | 0.38% | 59 |
|
|
2019
Q2 | $1.06M | Hold |
13,210
| – | – | 0.44% | 54 |
|
|
2019
Q1 | $1.01M | Sell |
13,210
-156
| -1% | -$11.9K | 0.43% | 55 |
|
|
2018
Q4 | $1.02M | Buy |
13,366
+599
| +5% | +$45.6K | 0.53% | 48 |
|
|
2018
Q3 | $930K | Buy |
12,767
+779
| +6% | +$56.7K | 0.52% | 53 |
|
|
2018
Q2 | $694K | Buy |
11,988
+3,205
| +36% | +$186K | 0.4% | 66 |
|
|
2018
Q1 | $457K | Sell |
8,783
-2,148
| -20% | -$112K | 0.3% | 73 |
|
|
2017
Q4 | $587K | Buy |
+10,931
| New | +$587K | 0.38% | 70 |
|